IDEX Biometrics ASA
IDXAF
$0.002
$0.001100.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 24.00K | 58.00K | 385.00K | 372.00K | 485.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 24.00K | 58.00K | 385.00K | 372.00K | 485.00K |
| Cost of Revenue | 1.19M | 28.00K | 233.00K | 237.00K | 1.12M |
| Gross Profit | -1.16M | 30.00K | 152.00K | 135.00K | -631.00K |
| SG&A Expenses | 1.26M | 1.86M | 2.53M | 3.15M | 2.35M |
| Depreciation & Amortization | 1.41M | -372.00K | 1.10M | 382.00K | 504.00K |
| Other Operating Expenses | 2.25M | 1.20M | 1.86M | 1.97M | 2.06M |
| Total Operating Expenses | 5.94M | 4.11M | 6.36M | 6.33M | 5.79M |
| Operating Income | -5.92M | -4.05M | -5.98M | -5.96M | -5.30M |
| Income Before Tax | -3.84M | 1.36M | -6.67M | -5.42M | -4.90M |
| Income Tax Expenses | -122.00K | -- | 2.00K | -- | 15.00K |
| Earnings from Continuing Operations | -3.72M | 1.36M | -6.67M | -5.42M | -4.92M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.72M | 1.36M | -6.67M | -5.42M | -4.92M |
| EBIT | -5.92M | -4.05M | -5.98M | -5.96M | -5.30M |
| EBITDA | -5.58M | -3.82M | -4.88M | -5.73M | -4.95M |
| EPS Basic | -0.01 | 0.00 | -0.02 | -0.02 | -0.02 |
| Normalized Basic EPS | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | 0.00 | -0.02 | -0.02 | -0.02 |
| Normalized Diluted EPS | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 527.91M | 313.21M | 291.57M | 279.57M | 279.06M |
| Average Diluted Shares Outstanding | 528.41M | 314.07M | 292.34M | 285.99M | 280.53M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |